drugset / Trial / NCT03565237
RIXUBIS PMS India (RIXUBIS PMS)
Phase 4
Completed
25 enrolled
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to characterize the safety and describe the effectiveness of RIXUBIS in routine clinical practice.
Timeline
- Start
- 2018-12-07
- Primary completion
- 2021-08-11
- Completion
- 2021-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BeneFIX | Protein / enzyme biologic | — | — |